Search Results - "Gil Negrete, A."

The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain by Vera, R, Castro, N, Labiano, I, Lecumberri, A, Huerta, A E, Arasanz, H, Caseda, I, Ruiz-Pace, F, Viaplana, C, Arrazubi, V, Hernandez-Garcia, I, Mata, E, Gomez, D, Laguna, S, Suarez, J, Fernandez-De-Los-Reyes, I, Rullan, M, Estremera, F, Alonso, V, Pazo-Cid, R, Gil-Negrete, A, Lafuente, A, Martin-Carnicero, A, Dientsmann, R, Alsina, M

“…Gastrointestinal cancers represent one of the most prevalent diseases worldwide. Strikingly, the incidence of Early Onset Gastrointestinal Cancer (EOGIC) has…”
Get full text

Correction: the TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain by Vera, R, Castro, N, Labiano, I, Lecumberri, A, Huerta, A E, Arasanz, H, Caseda, I, Ruiz-Pace, F, Viaplana, C, Arrazubi, V, Hernandez-Garcia, I, Mata, E, Gomez, D, Laguna, S, Suarez, J, Fernandez-De-Los-Reyes, I, Rullan, M, Estremera, F, Alonso, V, Pazo-Cid, R, Gil-Negrete, A, Lafuente, A, Martin-Carnicero, A, Dienstmann, R, Alsina, M

Get full text

Paclitaxel for progressive basal cell carcinoma by Barceló, Ramón, Viteri, Ainhoa, Muñoz, Alberto, Gil-Negrete, Aitziber, Rubio, Itziar, López-Vivanco, Guillermo

Get full text

First-line docetaxel (Dx) and capecitabine (Cap) in advanced head and neck cancer by Gil-Negrete, A., Mañe, J. M., Ruiz de Lobera, A., Martinez-Bueno, A., Rubio, I., Fuente, N., Lopez-Vivanco, G., Ancizar, N., Fernandez, R., Sancho, A.

“…Abstract only 16505 Background: Dx and Cap are useful drugs in head and neck cancer. Our purpose was to establish the efficacy and safety of this combination…”
Get full text

Nasopharyngeal carcinoma: Comparison of concomitant chemoradiotherapy with neoadjuvant chemotherapy in the caucasian population by Sancho, A., Rubio, I., Diaz de Corcuera, I., Munoz, A., Martinez-Bueno, A., Mane, J. M., Ruiz de Lobera, A., Fernandez-Rodriguez, R., Gil-Negrete, A., Carrera, S.

“…Abstract only 16532 Background: Nowadays, concomitant chemoradiotherapy (CT-RT) is the standard treatment for nasopharyngeal carcinoma (NPC). Neoadyuvant…”
Get full text

Treatment of locally advanced esophageal carcinoma with induction cisplatin-paclitaxel-5FU (PTF) before local therapy by Fernandez-Rodriguez, R., Ancizar, N., Lopez de Argumedo, G., Ruiz de Lobera, A., Lopez Vivanco, G., Gil Negrete, A., Sancho, A., Carrera, S., Munoz, A., Mane, J. M.

“…Abstract only 15174 Background: We analyse induction therapy with PTF before local definitive therapy in terms of response, resectability, toxicity and…”
Get full text

Value of postoperative adjuvant chemotherapy (ac) for patients with completely resected hepatic (hm) and/or pulmonary metastases (pm) from colorectal cancer (crc): retrospective analysis of 146 patients by Muñoz, A., Barceló, R., Gil-Negrete, A., Carrera, S., López-Argumedo, G., Ruiz de Lobera, A., Diaz de Corcuera, I., Rubio, I., Viteri, A., López-Vivanco, G.

“…Abstract only 13509 Background: AC is indicated for stage III and high risk stage II colon cancer, as well as for stages II-III rectal cancers combined with…”
Get full text

Elderly patients with advanced non-small cell lung cancer (nsclc). Results of chemotherapy and comparison with younger patients by Rubio, I., Martínez-Bueno, A., López-Vivanco, G., Fuente, N., Barceló, R., Gil-Negrete, A., Carrera, S., López-Argumedo, G., Fernández, R., Muñoz, A.

“…Abstract only 18505 Background: Lung cancer is increasingly diagnosed in elderly patients and is the first cause of cancer death. Treatment of this subset…”
Get full text

P-568 Treatment of advanced non small cell lung cancer (NSCLC) witha biweekly combination of cisplatin and prolonged infusion of gemcitabine by Rubio, I., Muñoz, A., López-Vivanco, G., Barceló, R., Lopez-Argumedo, G., Carrera, S., Gil-Negrete, A., Mañé, J., Muhialdin, J.

Get full text